Because there are results of a study of the drug newly approved for reducing elevated cholesterol levels that indicate it can cause problems with the kidneys and other organs, they have caused regulators to require that it now be dispensed with an additional warning on the label.
A. Because there are results of a study of the drug newly approved for reducing elevated cholesterol levels that indicate it can cause problems with the kidneys and other organs, they have caused regulators to require that it now be dispensed
B. Because a study's results indicate that the drug newly approved for reducing elevated cholesterol levels can cause problems with the kidneys and other organs, regulators require that the drug now be dispensed
C. The newly approved drug for reducing elevated cholesterol levels can cause problems with the kidneys and other organs, as indicated to regulators by the results of a study, so it is now required to be dispensed
D. Based on the results of a study, the drug newly approved for reducing elevated cholesterol levels can cause problems with the kidneys and other organs, so regulators require it to be dispensed now
E. Because regulators found in the results of a study that the drug newly approved for reducing elevated cholesterol levels can cause problems with the kidneys and other organs, so they are now requiring it to be dispensed